Clinical Trial Update: Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for asthma patients who are nonadherent to da…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Inhaled corticosteroid/long-acting beta-agonist combination therapy (Inhaled corticosteroid / long-acting beta-agonist)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Asthma, Nonadherence, Medication | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING